{"company":{"id":146,"name":"Sanofi","domain":"sanofi.com","url":"https://alion.io/company/sanofi"},"section":"news","answer":"Sanofi: 12 headlines on record, 7 headlines in the last 90 days. Its story counts 13 milestones.","figures":[{"label":"Headlines","value":"12"},{"label":"In 90 days","value":"7"},{"label":"Milestones","value":"13"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":12},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":13}],"news":[{"date":"2026-09-22","kind":"News","title":"Sanofi (SAN:CA) Presents at Bank of America Global Healthcare Conference 2026 Transcript","source":"seekingalpha.com","url":"https://seekingalpha.com/article/4948587-sanofi-san-ca-presents-at-bank-of-america-global-healthcare-conference-2026-transcript"},{"date":"2026-09-21","kind":"News","title":"Sanofi and Cheplapharm forge new medicines partnership","source":"PharmaTimes","url":"https://pharmatimes.com/news/sanofi-and-cheplapharm-forge-new-medicines-partnership/"},{"date":"2026-09-21","kind":"News","title":"Sanofi stock holds steady as investors weigh recent earnings and guidance","source":"Sanofi stock holds steady as investors weigh recent earnings and guidance","url":"https://ad-hoc-news.de/boerse/news/corporate-news/sanofi-stock-holds-steady-as-investors-weigh-recent-earnings-and-guidance/70143290"},{"date":"2026-09-18","kind":"News","title":"Sanofi Strikes Strategic Deal With Cheplapharm to Hand Over 20 Mature Medicines and Three Plants","source":"The Globe and Mail","url":"https://theglobeandmail.com/investing/markets/markets-news/Tipranks/4676075/sanofi-strikes-strategic-deal-with-cheplapharm-to-hand-over-20-mature-medicines-and-three-plants/"},{"date":"2026-09-15","kind":"News","title":"Sanofi strikes Cheplapharm deal to divest 20 older medicines as CEO pushes for innovation","source":"fiercepharma.com","url":"https://fiercepharma.com/pharma/sanofi-strikes-deal-cheplapharm-divest-20-older-medicines-new-ceos-push-innovation"},{"date":"2026-09-14","kind":"News","title":"Sanofi divesting older medicines, trio of manufacturing sites","source":"wfmz.com","url":"https://wfmz.com/news/area/poconos-coal/monroe-county/sanofi-divesting-older-medicines-trio-of-manufacturing-sites/article_d8e5d451-3f7d-414a-a469-1ec5785350d6.html"},{"date":"2026-09-14","kind":"News","title":"Sanofi Divests Older Medicines as New CEO Pushes for Innovation","source":"bloomberg.com","url":"https://bloomberg.com/news/articles/2026-09-14/sanofi-divests-older-medicines-as-new-ceo-pushes-for-innovation"},{"date":"2025-11-12","kind":"News","title":"Ontario considering order that would kill new rental homes","source":"cbc.ca","url":"https://cbc.ca/news/canada/toronto/ministers-zoning-order-sanofi-pasteur-apartments-9.6973633"},{"date":"2024-12-18","kind":"Press release","title":"Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn's Disease","source":"ir.tevapharm.com","url":"https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2024/Teva-and-Sanofi-Announce-Duvakitug-Anti-TL1A-Positive-Phase-2b-Results-Demonstrating-Best-in-Class-Potential-in-Ulcerative-Colitis-and-Crohns-Disease/default.aspx"},{"date":"2024-12-17","kind":"News","title":"Drugmakers say Crohn's drug met primary targets","source":"reuters.com","url":"https://reuters.com/business/healthcare-pharmaceuticals/teva-sanofi-say-drug-treat-ibd-met-primary-targets-2024-12-17/"},{"date":"2024-10-30","kind":"News","title":"Sanofi spins out its consumer healthcare business","source":"Chemistry World","url":"https://chemistryworld.com/news/sanofi-spins-out-its-consumer-healthcare-business/4020430.article"},{"date":"2024-05-21","kind":"News","title":"Sanofi partners with OpenAI, Formation Bio on AI-driven drug development","source":"reuters.com","url":"https://reuters.com/business/healthcare-pharmaceuticals/sanofi-partners-with-openai-formation-bio-ai-driven-drug-development-2024-05-21/"}],"story":[{"title":"Formerly French parent company Sanofi S.A. (vicebio.com)"},{"title":"Won a grant $281k · CORDIS","url":"https://cordis.europa.eu/project/id/101168878"},{"title":"Won a grant $281k · CORDIS","url":"https://cordis.europa.eu/project/id/101168916"},{"title":"Won a grant $563k · CORDIS","url":"https://cordis.europa.eu/project/id/101072780"},{"title":"Won a grant $281k · CORDIS","url":"https://cordis.europa.eu/project/id/101069949"},{"title":"Increased its share capital $2.7B · BODACC","url":"https://www.bodacc.fr/pages/annonces-commerciales-detail/?q.id=id:B202100462204"},{"title":"Increased its share capital $2.7B · BODACC","url":"https://www.bodacc.fr/pages/annonces-commerciales-detail/?q.id=id:B202000451212"},{"title":"Won a grant $87k · CORDIS","url":"https://cordis.europa.eu/project/id/691042"},{"title":"Won a grant $269k · CORDIS","url":"https://cordis.europa.eu/project/id/675071"},{"title":"Won a grant $269k · CORDIS","url":"https://cordis.europa.eu/project/id/643056"},{"title":"Renamed SANOFI · BODACC","url":"https://www.bodacc.fr/pages/annonces-commerciales-detail/?q.id=id:B201101031126"},{"title":"Incorporated SANOFI · recherche-entreprises"},{"title":"Founded"}],"as_of":"2026-11-15","cite":"Sanofi, News. Alion, Nov 15, 2026. https://alion.io/company/sanofi/news","html_url":"https://alion.io/company/sanofi/news","json_url":"https://alion.io/company/sanofi/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-15T22:38:35Z"}}